Gene therapy enters the pharma market: The short story of a long journey

Authors

  • Hildegard Büning

    Corresponding author
    1. Department I of Internal Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, CMMC Research Building, Cologne, Germany
    • Tel: +49 221 478 89611; Fax: +49 221 478 97332

    Search for more papers by this author
    • Hildegard Büning, PhD, heads the Laboratory for AAV Vector Development, University of Cologne, and is the President of the German Society for Gene Therapy (DG-GT e.V., http://www.dg-gt.de).


No abstract is available for this article.

Ancillary